New Clinical Advisory Issued by National Heart, Lung, and Blood Institute (NHLBI)

New Clinical Advisory Issued by National Heart, Lung, and Blood Institute (NHLBI). NLM Tech Bull. 2014 May-Jun;(398):b3.

The National Heart, Lung, and Blood Institute (NHLBI) issued a new Clinical Alert on May 15, 2014:

Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia (BMT CTN 0901)

The National Institutes of Health’s (NIH) NHLBI has suspended enrollment for the clinical study BMT CTN 0901 conducted by the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) after preliminary data appeared to show benefit for one approach to the intensity of conditioning for allogeneic stem cell transplantations in patients eligible for the study.